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As a field, surgery has generated some of the
leading innovators in history (1). Advances
in immunology and microbiology knowl-
edge and exciting technological develop-
ments, e.g., 3D imaging, robotic surgery,
natural orifice transluminal endoscopic
surgery, tissue engineering, and 3D print-
ing, will maintain the innovation potential
in the field of surgery on a high level.
Randomized controlled trials (RCTs)
represent the gold standard for evalua-
tion of the safety and efficacy of surgi-
cal interventions. There are several fac-
tors that make conduct of RCTs of surgi-
cal procedures particularly difficult. There-
fore in the past the majority of surgical
innovations were accepted on the basis of
non-randomized trials (2).
That was highlighted, in particular, by
the reaction to the introduction of laparo-
scopic cholecystectomy, which was greeted
by Sir Alfred Cushieri as the “greatest
unaudited procedure in the history of
surgery” (3).
The first minimally invasive
gallbladder-removal procedure was per-
formed by Mühe in Germany in 1985 using
a galloscope he himself had designed (4),
and the first video-endoscopic cholecystec-
tomy was carried out by Mouret in France
in 1987 (3). The first case series was then
published by Dubois in 1989 with 63 cases
(5), and by Perissat in 1992 with 777 cases
(6). By that time, laparoscopic cholecys-
tectomy had already become established in
many hospitals worldwide. A problematic
issue during that phase of “scientific uncer-
tainty” was the significantly higher rate
of common bile duct injuries, especially
during the learning curve (7).
The first report on a prospective ran-
domized trial comparing laparoscopic with
open cholecystectomy were published in
1992, attesting to the benefits of the mini-
mally invasive technique (8). However, the
sample size in that first RCT was only
70 patients. It was only in 2006, when
the Cochrane Collaboration reviewed in
a meta-analysis of 38 RCTs with 2,338
patients, i.e., on average 62 patients per
study, that it was possible to issue a scientif-
ically corroborated statement demonstrat-
ing that laparoscopic cholecystectomy did
not differ from the open technique in terms
of mortality, complication rate, or operat-
ing time, but did result in a shorter hospital
stay and quicker convalescence (9).
The authors thus concluded that “these
results confirm the existing preference
for the laparoscopic cholecystectomy over
open cholecystectomy.”
It thus took 20 years from the initial
introduction of video-endoscopic chole-
cystectomy until scientific proof of its
benefits to the patients could be demon-
strated. That proof, of the highest level
of evidence according to the Oxford cri-
teria, was obtained from the RCT gold
standard and meta-analysis. By that time,
laparoscopic cholecystectomy had already
become established as the gold standard in
all hospitals worldwide.
As a reaction to the analysis of how
innovations were taking place in surgery,
an expert group was set up within the
framework of the Balliol Collaboration
to compile recommendations for scientific
evaluation of surgical innovations. In that
spirit, McCulloch (10) stated that “in the
short term, we cannot change how surgical
innovations happen and so we need to
adapt our methods to the process rather
than doing the opposite.”
In addition, the Balliol Collaboration
highlighted the special features of this sur-
gical innovation process: “By contrast with
the formalized approach for drug devel-
opments, the process in surgery has been
unregulated, unstructured, and variable.
Surgery and other invasive therapies are
complex interventions, the assessment of
which is challenged by factors that depend
on operator, team, and setting, such as
learning curves, quality variations, and
perception of equipoise” (10).
To take account of how surgical inno-
vations take place in reality, the Balliol
Collaboration recommends that details of
patients treated with the new technique
be recorded in prospective development
studies, prospective research databases, or
prospective registries. These prospectively
recorded data will provide for a better
power calculation for RCTs, indications can
be formulated for this new technique and
quality criteria identified (10). As such,
prospectively recorded registry data can
play an important role in the development
of high-caliber RCTs since the prospec-
tive registry data can pave the way for an
enhanced study design for RCTs. In partic-
ular, this would cut back on the need for
RCTs with a relatively small sample size,
while reserving resources for those RCTs
endowed with adequate power.
A good example of early scientific eval-
uation of surgical innovation by means
of a prospective research database is the
NOTES registry of the German Society
of General and Visceral Surgery. Data on
all procedures related to natural orifices
(transgastral, transrectal, and transvagi-
nal) can be entered into the registry for
Natural Orifice Transluminal Endoscopic
Surgery. The national NOTES registry was
set up by the German Society of Gen-
eral and Visceral Surgery to collect data
on implementation of the new technique.
The aim is to draw on past experiences

























































Köckerling Need for registries in surgery
gathered at the time of introducing min-
imally invasive surgery and identify any
problems at an early stage. By the end
of February 2014, data on 3,211 NOTES
operations had been entered into the reg-
istry. The initial results of 551 proce-
dures were published in 2010 in Annals of
Surgery (11). These data demonstrated that
transvaginal cholecystectomy can be per-
formed to the required safety standard as
an alternative to laparoscopic cholecystec-
tomy.
Another example is the various her-
nia registries (Herniamed, Danish Hernia
Registry, Swedish Hernia Registry, EuraHS,
etc.). Hernia surgery, in particular, has
experienced rapid progress in recent years.
By virtue of the ever-expanding number
of medical devices used in hernia surgery
(meshes, tackers, and sealants), the surgi-
cal techniques are of such a broad variety
that they can scarcely be evaluated in a
RCT. But by consistently recording details
of the different surgical techniques in a
prospective registry, any problems or com-
plications related to particular variants of
the technique can be identified at an early
stage (12).
The voluntary recall of a metal-on-
metal hip implant from the market around
the world is an excellent example for the
validity of registries in the early iden-
tification of complications with a spe-
cific surgical procedure. The reason that
the company has done this was due
to the analysis of data from the Aus-
tralian National Joint Replacement Reg-
istry demonstrating that the rate of early
revision surgery for these implants was
higher relative to other hip replacements.
Additionally, there are concerns about
metal-on-metal hip implants and the pos-
sibility of adverse health consequences of
metal particles and metal ions that may
generated by wear of the components of
these implants (13).
In summary, the innovation process in
surgery is essentially more unstructured,
unregulated, and variable than in conser-
vative medicine. Scientific evaluation of
surgical innovations must be adapted to
take account of that. In addition to the
gold standard of evidence-based medicine,
i.e., the RCT, surgical innovations should
in parallel involve prospective recording
of data on patients in a database, i.e., a
registry. This will provide for early iden-
tification of any problems or complica-
tions on the basis of outcome analysis.
In the surgical innovation process, reg-
istries constitute an important scientific
tool that affords insights from the out-
set and accordingly merits evaluation. All
scientists engaged in surgical innovations
are called upon to support and promote
the development of such registries. Sur-
geons who themselves create innovations
should enter data into a registry on patients
treated as per the innovative technique.
The challenge is getting surgeons to be
more critical about the outcomes of their
innovations.
REFERENCES
1. Riskin DJ, Longaker MT, Gertner M, Krummel
TM. Innovation in surgery – a historical perspec-
tive. Ann Surg (2006) 244:686–93. doi:10.1097/01.
sla.0000242706.91771.ce
2. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien
PA, Reevers BC, et al. Challenges in evaluating
surgical innovation. Lancet (2009) 374:1097–104.
doi:10.1016/S0140-6736(09)61086-2
3. Berci G, Forde KA. History of endoscopy.
Surg Endosc (2000) 14:5–15. doi:10.1007/
s004649900002
4. Mühe E. Die erste Cholecystektomie durch
das Laparoskop. Langenbeck’s Arch Surg (1986)
386:804.
5. Dubois F, Berthelot G, Levard H. Cholecystectomy
by coelioscopy. Presse Med (1989) 18:980–2.
6. Perissat J, Collet D, Edye M, Magne E, Bel-
liard R, Desplantez J. Laparoscopic cholecystec-
tomy: an analysis of 777 cases. Baillieres Clin
Gastroenterol (1992) 6:727–42. doi:10.1016/0950-
3528(92)90050-O
7. Flum DR, Dellinger EP, Cheadle A, Chan L,
Koepsell T. Intraoperative cholangiography and
risk of common bile duct injury during cholecys-
tectomy. JAMA (2003) 289:1639–44. doi:10.1001/
jama.289.13.1639
8. Barkun JS, Barkun AN, Sampalis JS, Fried G, Tay-
lor B, Wexler MJ, et al. Randomised controlled trial
of laparoscopic versus mini cholecystectomy. The
McGill Gallstone Treatment Group. Lancet (1992)
340:1116–9. doi:10.1016/0140-6736(92)93148-G
9. Keus F, de Jong JA, Gooszen HG, van Laarhoven
CJ. Laparoscopic versus open cholecystectomy
for patients with symptomatic cholecystolithiasis.
Cochrane Database Syst Rev (2006) 18:DC006231.
doi:10.1002/14651858.CD006231
10. McCulloch P, Altmann DG, Campell WB, Flum
DR, Glaszious P, Marshal JC, et al. Surgical inno-
vation and evaluation 3 – no surgical innovation
without evaluation: the IDEAL recommendations.
Lancet (2009) 374:1105–12. doi:10.1016/S0140-
6736(09)61116-8
11. Lehmann KS, Ritz JP, Wibmer A, Gellert K, Zornig
C, Burghardt J, et al. The German registry for
natural orifice translumenal endoscopic surgery:
report of the first 551 patients. Ann Surg (2010)
252:263–70. doi:10.1097/SLA.0b013e3181e6240f
12. Stechemesser B, Jacob DA, Schug-Paß C, Köcker-
ling F. Herniamed: an internet-based registry for
outcome research in hernia surgery. Hernia (2012)
16:269–76. doi:10.1007/s10029-012-0908-3
13. Australian Government – Department of Health.
Available from: http://www.tga.gov.au/hp/
information-devices-mom-hip-implants.htm
Conflict of Interest Statement: The author declares
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 10 March 2014; accepted: 14 April 2014;
published online: 28 April 2014.
Citation: Köckerling F (2014) The need for registries in
the early scientific evaluation of surgical innovations.
Front. Surg. 1:12. doi:10.3389/ fsurg.2014.00012
This article was submitted to the journal Frontiers in
Surgery.
Copyright © 2014 Köckerling . This is an open-access
article distributed under the terms of the Creative Com-
mons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with
these terms.
Frontiers in Surgery www.frontiersin.org April 2014 | Volume 1 | Article 12 | 2
